TES Pharma Congratulates Intercept Pharmaceuticals on their Pr... - 09 November 2022 11:00

PERUGIA, Italy, Nov. 9, 2022, /PRNewswire-AsiaNet/-- INT-787 is a selective next generation FXR agonist invented by TES Pharma and licensed to Intercept Pharmaceuticals INT-787 has shown strong anti-fibrotic and anti-inflammatory effects in animal models TES Pharma is dedicated to the identifi...

  Novavax Phase 3 COVID-19 Omicron Trial Supports the Continued ... - 09 November 2022 01:51

GAITHERSBURG, Md., Nov. 8, 2022 /PRNewswire-AsiaNet/ -- -- The Novavax BA.1 vaccine candidate met its primary strain-change endpoint allowing for development of variant vaccines, if necessary -- Novavax' prototype vaccine induced broad immune response against original Wuhan, BA.1, and BA.5 strains --...

  EIT Health's Venture Centre of Excellence Names ProductLife Gr... - 08 November 2022 20:00

PARIS, Nov. 8, 2022 /PRNewswire-AsiaNet/ -- - The ambitious EU initiative has already secured 2 billion euros of co-investment capabilities and has supported 60 innovative Biotech, Medtech & digital health start-ups to get to market or expand into new territories. - EIT Health, co-operator...

  OMRON Declares Its Commitment to Doubling Energy Productivity ... - 08 November 2022 16:00

KYOTO, Japan, Nov. 8, 2022 /Kyodo JBN-AsiaNet/ -- OMRON Corporation headquartered in Shimogyo-ku, Kyoto, became a member of The Climate Group's "EP100" (*1) initiatives. OMRON is the first Japanese company in the manufacturing industry and the fourth Japanese company in general to join the EP100 ...

  Turn Biotechnologies Names 25-year Biotech Industry Veteran Ri... - 03 November 2022 00:00

MOUNTAIN VIEW, Calif., Nov. 2, 2022 /PRNewswire-AsiaNet/ -- -- Seasoned Executive has Successful Track Record Working with Global Investors to Raise Billions of Dollars Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today an...

  NCCN Working with Medlive to Advance High-Quality Cancer Care ... - 02 November 2022 12:04

PLYMOUTH MEETING, Pa., Nov. 2, 2022 /PRNewswire-AsiaNet/ -- --United States-based National Comprehensive Cancer Network enters strategic cooperation agreement with Chinese medical information website to publish and translate evidence-based expert consensus guidelines for cancer care; now available at nccnc...

  Karyopharm and Menarini Group Announce Orphan Medicinal Produc... - 01 November 2022 23:02

NEWTON, Mass. and FLORENCE, Italy, Nov. 1, 2022 /PRNewswire-AsiaNet/ -- Karyopharm Therapeutics Inc. (NASDAQ: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, and the Menarini Group ("Menarini"), a privately-held, leading international pharmaceutical company, today announced that the...

  Pervistop[R], the once-daily supplement specifically designed ... - 01 November 2022 19:00

FRANKFURT, Germany Nov. 1, 2022 /PRNewswire-AsiaNet/ -- - Lo.Li. Pharma International to unveil an innovative new product at CPHI Frankfurt, which has already gained the interest of numerous distribution partners. Pervistop[R] promises to be an extremely effective tool in the management of an exceedi...

  EpiVax Joins Intravacc, CEPI on Project to Develop Universal B... - 31 October 2022 23:00

PROVIDENCE, R.I., Oct. 31, 2022 /PRNewswire-AsiaNet/ -- EpiVax, Inc. ("EpiVax") is pleased to announce participation in a new project with Intravacc, funded by CEPI (Coalition for Epidemic Preparedness Innovations), to develop universal vaccines for betacoronaviruses, including SARS-CoV-2. EpiVax will ...

  Taimei Technology receives TRUSTe Enterprise Privacy Certifica... - 31 October 2022 20:04

SHANGHAI, Oct. 31, 2022 /PRNewswire-AsiaNet/ Taimei Technology, a digital operation platform for the life science industry, announced that it has recently received the TRUSTe Enterprise Privacy Certification from TrustArc, a global leader in privacy solutions. The certification is a testamen...